Related Experiment Video
Updated: Aug 24, 2026

RhoC GTPase Activation Assay
Published on: August 22, 2010
CGA gene (coding for the alpha subunit of glycoprotein hormones) overexpression in ER alpha-positive prostate tumors
Ivan Bièche1, Alain Latil, Béatrice Parfait
1Laboratoire de Génétique Moléculaire-UPRES JE 2195, Faculté des Sciences Pharmaceutiques et Biologiques de Paris, Université René Descartes-Paris V, 4 Avenue de l'Observatoire, F-75006 Paris, France.
Objective:
The precise role of estrogen, estrogen receptor (ER) and ER-responsive genes in prostate carcinogenesis is unclear. Paradoxically, estrogens and antiestrogens are used in the treatment of advanced metastatic prostate cancers. Recently, we identified CGA gene coding for the alpha subunit of glycoprotein hormones as a new ER alpha-responsive gene in human breast cancer cells. The aim of this study was to explore the role of CGA in the second major hormone-related cancer, i.e. prostate cancer.
Patients And Methods:
We quantified CGA mRNA in nine cases of benign prostatic hyperplasia (BPH) and 23 sporadic prostate tumors (TP) by using a real-time quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) assay.
Results:
CGA overexpression (> 10 S.D. above the mean in normal prostate tissues (NP)) was observed in 39% of the TP (ranging from 4.4 to 174.5 times the level in NP) and in none of the BPH samples. CGA overexpression was not accompanied by overexpression of the CGB, LHB, TSHB or FSHB genes to produce ectopic glycoprotein hormones. CGA gene overexpression correlated with ER alpha normal expression (P = 0.016), but not with ER beta or androgen receptor (AR) expression status.
Conclusion:
These results point to CGA gene as a member of a novel dysregulated pathway in prostate cancer. CGA should therefore be considered for investigation as possible novel molecular marker in clinical applications and as possible new potential therapeutic target.
Insights
The CGA gene is overexpressed in 39% of prostate tumors, correlating with estrogen receptor alpha. This suggests CGA may be a novel molecular marker and therapeutic target for prostate cancer.
Area of Science:
- Endocrinology
- Oncology
- Molecular Biology
Background:
- The role of estrogen and its receptors in prostate cancer is not fully understood.
- Estrogen- and antiestrogen therapies are paradoxically used for advanced prostate cancer.
- The CGA gene, encoding the alpha subunit of glycoprotein hormones, was recently identified as an estrogen receptor alpha-responsive gene in breast cancer cells.
Purpose of the Study:
- To investigate the role of the CGA gene in prostate cancer.
- To determine if CGA is dysregulated in prostate tumors.
- To explore the association between CGA expression and estrogen receptor status in prostate cancer.
Main Methods:
- Quantification of CGA mRNA in benign prostatic hyperplasia (BPH) and prostate tumor (TP) tissues using real-time quantitative reverse transcriptase-polymerase chain reaction (RT-PCR).
- Analysis of CGA overexpression relative to normal prostate tissues (NP).
- Correlation analysis of CGA expression with estrogen receptor alpha (ER alpha), estrogen receptor beta (ER beta), and androgen receptor (AR) expression.
Main Results:
- CGA overexpression was observed in 39% of prostate tumors, with levels significantly higher than in normal prostate tissues.
- No CGA overexpression was detected in benign prostatic hyperplasia samples.
- CGA gene overexpression correlated significantly with normal ER alpha expression but not with ER beta or AR expression.
Conclusions:
- The CGA gene represents a novel dysregulated pathway in prostate cancer.
- CGA may serve as a potential molecular marker for prostate cancer diagnosis and prognosis.
- CGA warrants further investigation as a potential therapeutic target in prostate cancer treatment.
Related Concept Videos
Cell Specific Gene Expression
Mitogens and the Cell Cycle
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Ras Gene
Ras is a superfamily...
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Activation and Inactivation of G Proteins

